[Acute renal failure as a complication of transarterial chemoembolization in a patient with hepatocellular carcinoma].
Transarterial chemoembolization (TACE) is included among the wide therapeutic tools for the treatment of hepatocellular carcinoma (HCC), tumour with high frequency and malignancy. The approach is invasive and, beyond the discomfort for the patient, it is charged by a number of side effects and complications. In this study we report the case of renal acute failure of hypovolemic origin, as a consequence of a TACE in a patient suffering from HCC, occurred after one week of intervention. The different possible mechanisms involved in the pathogenesis of this complication are discussed.
La Spada
Emanuele
E
Cattedra di Medicina Interna e d'Urgenza, Università, Palermo.
La Spada
Monica
M
Brusca
Tiziana
T
Campagna
M Elisa
ME
Di Gesaro
Valeria
V
Terranova
Angela
A
Sandonato
Luigi
L
Soresi
Maurizio
M
D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000628:therapy; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D016461:Chemoembolization, Therapeutic / Q000009:adverse effects*; D006801:Humans; D007261:Infusions, Intra-Arterial; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male; D012307:Risk Factors; D016896:Treatment Outcome
D000970:Antineoplastic Agents